179 related articles for article (PubMed ID: 21121345)
1. Development and characterization of triazine based dendrimers for delivery of antitumor agent.
Bansal KK; Kakde D; Gupta U; Jain NK
J Nanosci Nanotechnol; 2010 Dec; 10(12):8395-404. PubMed ID: 21121345
[TBL] [Abstract][Full Text] [Related]
2. Design, synthesis, characterization, and biological evaluation of triazine dendrimers bearing paclitaxel using ester and ester/disulfide linkages.
Lim J; Chouai A; Lo ST; Liu W; Sun X; Simanek EE
Bioconjug Chem; 2009 Nov; 20(11):2154-61. PubMed ID: 19877601
[TBL] [Abstract][Full Text] [Related]
3. One platform comparison of solubilization potential of dendrimer with some solubilizing agents.
Jain S; Kesharwani P; Tekade RK; Jain NK
Drug Dev Ind Pharm; 2015 May; 41(5):722-7. PubMed ID: 24641446
[TBL] [Abstract][Full Text] [Related]
4. Triazine dendrimers as drug delivery systems: from synthesis to therapy.
Lim J; Simanek EE
Adv Drug Deliv Rev; 2012 Jun; 64(9):826-35. PubMed ID: 22465784
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of water-soluble dendrimers based on melamine bearing 16 paclitaxel groups.
Lim J; Simanek EE
Org Lett; 2008 Jan; 10(2):201-4. PubMed ID: 18088131
[TBL] [Abstract][Full Text] [Related]
6. Biological assessment of triazine dendrimer: toxicological profiles, solution behavior, biodistribution, drug release and efficacy in a PEGylated, paclitaxel construct.
Lo ST; Stern S; Clogston JD; Zheng J; Adiseshaiah PP; Dobrovolskaia M; Lim J; Patri AK; Sun X; Simanek EE
Mol Pharm; 2010 Aug; 7(4):993-1006. PubMed ID: 20481608
[TBL] [Abstract][Full Text] [Related]
7. Design, synthesis and biological assessment of a triazine dendrimer with approximately 16 Paclitaxel groups and 8 PEG groups.
Lee C; Lo ST; Lim J; da Costa VC; Ramezani S; Öz OK; Pavan GM; Annunziata O; Sun X; Simanek EE
Mol Pharm; 2013 Dec; 10(12):4452-61. PubMed ID: 24134039
[TBL] [Abstract][Full Text] [Related]
8. Experimental and computational evidence for an inversion in guest capacity in high-generation triazine dendrimer hosts.
Lim J; Pavan GM; Annunziata O; Simanek EE
J Am Chem Soc; 2012 Feb; 134(4):1942-5. PubMed ID: 22239724
[TBL] [Abstract][Full Text] [Related]
9. Synthesis and characterization of a triazine dendrimer that sequesters iron(III) using 12 desferrioxamine B groups.
Lim J; Venditto VJ; Simanek EE
Bioorg Med Chem; 2010 Aug; 18(15):5749-53. PubMed ID: 20615715
[TBL] [Abstract][Full Text] [Related]
10. Dendrimer-TPGS mixed micelles for enhanced solubility and cellular toxicity of taxanes.
Pooja D; Kulhari H; Singh MK; Mukherjee S; Rachamalla SS; Sistla R
Colloids Surf B Biointerfaces; 2014 Sep; 121():461-8. PubMed ID: 25063311
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and evaluation of novel dendrimers with a hydrophilic interior as nanocarriers for drug delivery.
Dhanikula RS; Hildgen P
Bioconjug Chem; 2006; 17(1):29-41. PubMed ID: 16417249
[TBL] [Abstract][Full Text] [Related]
12. Cytotoxicity, hemolysis, and acute in vivo toxicity of dendrimers based on melamine, candidate vehicles for drug delivery.
Chen HT; Neerman MF; Parrish AR; Simanek EE
J Am Chem Soc; 2004 Aug; 126(32):10044-8. PubMed ID: 15303879
[TBL] [Abstract][Full Text] [Related]
13. Synthesis of odd generation triazine dendrimers using a divergent, macromonomer approach.
Lim J; Mintzer MA; Perez LM; Simanek EE
Org Lett; 2010 Mar; 12(6):1148-51. PubMed ID: 20170155
[TBL] [Abstract][Full Text] [Related]
14. Intercepting the synthesis of triazine dendrimers with nucleophilic pharmacophores: a general strategy toward drug delivery vehicles.
Venditto VJ; Allred K; Allred CD; Simanek EE
Chem Commun (Camb); 2009 Oct; (37):5541-2. PubMed ID: 19753350
[TBL] [Abstract][Full Text] [Related]
15. Preparation and in vitro characterization of pluronic-attached polyamidoamine dendrimers for drug delivery.
Gu Z; Wang M; Fang Q; Zheng H; Wu F; Lin D; Xu Y; Jin Y
Drug Dev Ind Pharm; 2015 May; 41(5):812-8. PubMed ID: 24745851
[TBL] [Abstract][Full Text] [Related]
16. Double targeting of tumours with pyrenyl-modified dendrimers encapsulated in an arene-ruthenium metallaprism.
Pitto-Barry A; Barry NP; Zava O; Deschenaux R; Dyson PJ; Therrien B
Chemistry; 2011 Feb; 17(6):1966-71. PubMed ID: 21274948
[TBL] [Abstract][Full Text] [Related]
17. Molecular modeling and in vivo imaging can identify successful flexible triazine dendrimer-based siRNA delivery systems.
Merkel OM; Zheng M; Mintzer MA; Pavan GM; Librizzi D; Maly M; Höffken H; Danani A; Simanek EE; Kissel T
J Control Release; 2011 Jul; 153(1):23-33. PubMed ID: 21342661
[TBL] [Abstract][Full Text] [Related]
18. Polypropyleneimine and polyamidoamine dendrimer mediated enhanced solubilization of bortezomib: Comparison and evaluation of mechanistic aspects by thermodynamics and molecular simulations.
Chaudhary S; Gothwal A; Khan I; Srivastava S; Malik R; Gupta U
Mater Sci Eng C Mater Biol Appl; 2017 Mar; 72():611-619. PubMed ID: 28024628
[TBL] [Abstract][Full Text] [Related]
19. Triazine dendrimers as nonviral vectors for in vitro and in vivo RNAi: the effects of peripheral groups and core structure on biological activity.
Merkel OM; Mintzer MA; Librizzi D; Samsonova O; Dicke T; Sproat B; Garn H; Barth PJ; Simanek EE; Kissel T
Mol Pharm; 2010 Aug; 7(4):969-83. PubMed ID: 20524664
[TBL] [Abstract][Full Text] [Related]
20. Nanosized dendritic polyguanidilyated translocators for enhanced solubility, permeability, and delivery of gatifloxacin.
Durairaj C; Kadam RS; Chandler JW; Hutcherson SL; Kompella UB
Invest Ophthalmol Vis Sci; 2010 Nov; 51(11):5804-16. PubMed ID: 20484584
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
